See more : Koan Hao Technology Co., Ltd. (8354.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Scandinavian ChemoTech AB (publ), a leading company in the Biotechnology industry within the Healthcare sector.
- Brookfield Infrastructure Finance ULC (BIPJ) Income Statement Analysis – Financial Results
- Catalyst Biosciences, Inc. (CBIO) Income Statement Analysis – Financial Results
- Martifer SGPS, S.A. (MAR.LS) Income Statement Analysis – Financial Results
- Sinotruk (Hong Kong) Limited (3808.HK) Income Statement Analysis – Financial Results
- FTAC Zeus Acquisition Corp. (ZINGU) Income Statement Analysis – Financial Results
Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)
About Scandinavian ChemoTech AB (publ)
Scandinavian ChemoTech AB (publ) provides cancer care and pain management solutions. Its product, IQWave, is an electroporation device, which combines short electric pulses with chemotherapy administrated locally or intravenously used for treating head and neck squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma. The company markets its products through distribution channels and a network of opinion leaders in South East Asia, India, and the Philippines. Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.82M | 473.00K | 49.00K | 131.00K | 556.00K | 560.00K | 27.24K | 2.08M | 13.89K | 0.00 | 0.00 |
| Cost of Revenue | 1.16M | 528.00K | -274.00K | 145.00K | 227.00K | 258.00K | 8.30M | 107.27K | 7.88K | 28.14K | 0.00 |
| Gross Profit | 1.66M | -55.00K | 323.00K | -14.00K | 329.00K | 302.00K | -8.28M | 1.98M | 6.01K | -28.14K | 0.00 |
| Gross Profit Ratio | 58.75% | -11.63% | 659.18% | -10.69% | 59.17% | 53.93% | -30,383.52% | 94.85% | 43.28% | 0.00% | 0.00% |
| Research & Development | 2.57M | 2.91M | -2.54M | -1.28M | -4.10M | -3.85M | 0.00 | 769.00K | -781.35K | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 6.67M | 11.73M | 6.64M | 0.00 | 0.00 | 1.81M | 27.78K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 19.12M | 17.86M | 16.96M | 6.67M | 11.73M | 6.64M | 18.93K | 9.63M | 1.81M | 27.78K | 7.46K |
| Other Expenses | 207.00K | 20.86M | 19.94M | 5.43M | 4.67M | 2.33M | 16.17K | 0.00 | 128.87K | 357.00 | 0.00 |
| Operating Expenses | 21.90M | 20.86M | 17.40M | 10.82M | 12.30M | 5.12M | 2.76K | 10.06M | 1.16M | 28.14K | 7.46K |
| Cost & Expenses | 23.06M | 21.39M | 17.13M | 10.96M | 12.53M | 5.38M | 8.31M | 10.17M | 1.16M | 28.14K | 7.46K |
| Interest Income | 549.00K | 63.00K | 9.00K | 0.00 | 4.00K | 96.00K | 0.00 | 53.63K | 101.00 | 0.00 | 0.00 |
| Interest Expense | 1.40M | 1.90M | 675.00K | 835.00K | 260.00K | 76.00K | 0.00 | 0.00 | 31.88K | 0.00 | 0.00 |
| Depreciation & Amortization | 109.00K | 41.00K | 42.00K | 56.00K | 49.00K | 47.00K | 543.95K | 412.73K | 101.00 | 357.00 | 7.46K |
| EBITDA | -19.58M | -20.81M | -17.03M | -10.77M | -12.02M | -8.04M | -7.72M | -7.65M | -1.15M | -27.78K | 0.00 |
| EBITDA Ratio | -693.80% | -3,784.57% | -29,085.71% | -6,794.66% | -1,841.73% | -637.32% | -28,396.98% | -366.90% | -8,269.40% | 0.00% | 0.00% |
| Operating Income | -20.14M | -20.91M | -17.08M | -10.83M | -11.97M | -4.82M | -8.28M | -8.06M | -1.15M | -28.14K | -7.46K |
| Operating Income Ratio | -713.64% | -4,421.14% | -34,851.02% | -8,266.41% | -2,153.06% | -860.18% | -30,393.64% | -386.70% | -8,270.12% | 0.00% | 0.00% |
| Total Other Income/Expenses | -952.00K | -1.83M | -666.00K | -835.00K | -354.00K | 62.00K | -51.47K | -53.63K | -31.78K | 0.00 | 0.00 |
| Income Before Tax | -21.09M | -22.75M | -17.74M | -11.66M | -12.33M | -4.80M | -8.33M | -8.14M | -1.18M | -28.14K | -7.46K |
| Income Before Tax Ratio | -747.38% | -4,808.88% | -36,210.20% | -8,903.82% | -2,216.73% | -856.61% | -30,582.56% | -390.48% | -8,498.88% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 1.83M | 675.00K | 835.00K | 260.00K | -20.00K | 5.00 | 0.00 | -101.00 | 3.00 | 0.00 |
| Net Income | -21.09M | -24.58M | -18.42M | -12.50M | -12.59M | -4.80M | -8.33M | -8.14M | -1.18M | -28.14K | -7.46K |
| Net Income Ratio | -747.38% | -5,196.62% | -37,587.76% | -9,541.22% | -2,263.49% | -856.61% | -30,582.56% | -390.48% | -8,498.88% | 0.00% | 0.00% |
| EPS | -1.13 | -2.47 | -2.13 | -2.54 | -3.06 | -1.47 | -5.70 | -5.57 | -1.03 | -0.02 | -0.01 |
| EPS Diluted | -1.13 | -2.47 | -2.13 | -2.54 | -3.06 | -1.47 | -5.70 | -5.57 | -1.03 | -0.02 | 0.00 |
| Weighted Avg Shares Out | 18.60M | 9.97M | 8.66M | 4.92M | 4.11M | 3.26M | 1.46M | 1.46M | 1.15M | 1.16M | 1.16M |
| Weighted Avg Shares Out (Dil) | 18.60M | 9.97M | 8.66M | 4.92M | 4.11M | 3.26M | 1.46M | 1.46M | 1.15M | 1.70M | 1.70M |
Source: https://incomestatements.info
Category: Stock Reports